Lycia Therapeutics, Inc.
Filed Oct 5, 2026.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Oct 5, 2026
Contents
EXPERTS
The financial statements of Lycia Therapeutics, Inc. as of December 31, 2024 and 2025 and for each of the years in the two-year period ended December 31, 2025, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in auditing and accounting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.